Fuse Oncology

Greensboro, United States

Fuse Oncology provides business and clinical intelligence solution for radiation oncology.

$8.9M raised

Apr 2023

Series A

Health Care Information Technology Medical Oncology Software

Top Investors

Cone HealthNortheast Georgia Health SystemFirst Launch Capital Fund

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Fuse Oncology

How much funding has Fuse Oncology raised?

Fuse Oncology has raised $8.9M in total funding. The most recent round was Series A. The last funding was announced in April 2023.

Who are Fuse Oncology's investors?

Fuse Oncology's investors include Cone Health, Northeast Georgia Health System, First Launch Capital Fund.

Where is Fuse Oncology headquartered?

Fuse Oncology is headquartered in Greensboro, United States.

What does Fuse Oncology do?

Fuse Oncology provides business and clinical intelligence solution for radiation oncology.

What stage is Fuse Oncology at?

Fuse Oncology is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 21, 2023.

MLA

"Fuse Oncology — Funding & Investors." VCBacked, April 21, 2023, https://www.vcbacked.co/company/fuse-oncology. Accessed June 17, 2026.

APA

VCBacked. (2023). Fuse Oncology — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/fuse-oncology

Wikipedia (cite web)

{{cite web |title=Fuse Oncology — Funding & Investors |url=https://www.vcbacked.co/company/fuse-oncology |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 21, 2023.

Similar Companies in Health Care